Table 3.
Examination type and iodixanol administration information (all enrolled patients)
| Parameter | Statistics | n (%) |
|---|---|---|
| Examination type | CECT | 5158 (25.6) |
| CCTA | 3585 (17.8) | |
| Diagnostic CAG | 4114 (20.4) | |
| CAG + PCI | 3940 (19.5) | |
| IR | 3391 (16.8) | |
| Iodixanol concentration | 270 mg I ml−1 | 379 (1.9) |
| 320 mg I ml−1 | 19 806 (98.1) | |
| Contrast pre-heated to body temperature | Yes | 8760 (43.4) |
| No | 11 425 (56.6) | |
| Status of artery/vein | Good | 18 093 (89.6) |
| Moderate | 1898 (9.4) | |
| Poor | 174 (0.9) | |
| Contrast volume (ml) | Mean | 95.9 |
| Min–max | 20–600 | |
| Contrast volume category (ml) | 0–50 | 2838 (14.1) |
| 51–80 | 6727 (33.3) | |
| 81–100 | 7321 (36.3) | |
| >100 | 3299 (16.3) | |
| Administration route | Artery | 11 049 (54.7) |
| Vein | 9112 (45.1) | |
| Othera | 24 (0.1) | |
| Injection mode | Manual | 7238 (35.9) |
| Automatic | 12 653 (62.7) | |
| Manual and automatic | 293 (1.5) | |
| Otherb | 1 (0.0) | |
| Flow rate (ml s−1) | Mean | 4.28 |
| Min–max | 1.0–25.0 | |
| Flow rate category (ml s−1) | ≤2 | 408 (2.0) |
| 2–3 | 4071 (20.2) | |
| 3–4 | 2908 (14.4) | |
| 4–5 | 3531 (17.5) | |
| >5 | 1766 (8.7) |
CAG, coronary angiography; CCTA, coronary CT angiography; CECT, contrast-enhanced CT; IR, interventional radiology; max, maximum; min, minimum; PCI, percutaneous coronary intervention.
a
Administration route: other included oral, oesophageal, biliary tract, subcutaneous, or percutaneous bilateral renal calyces administration.
b
Injection mode: other is oesophageal dosing.